home / stock / pcrx / pcrx news


PCRX News and Press, Pacira BioSciences Inc. From 03/08/24

Stock Information

Company Name: Pacira BioSciences Inc.
Stock Symbol: PCRX
Market: NASDAQ
Website: pacira.com

Menu

PCRX PCRX Quote PCRX Short PCRX News PCRX Articles PCRX Message Board
Get PCRX Alerts

News, Short Squeeze, Breakout and More Instantly...

PCRX - Teva upgraded at J.P. Morgan on upcoming catalysts

2024-03-08 10:21:57 ET More on Teva Pharmaceutical Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities Teva Pharmaceutical: I Need To See Top-Line Growth Return Before Starting A Position A Review Of Teva's Prospects UroGen falls as Te...

PCRX - Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference

TAMPA, Fla., March 06, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Barclays 26 th Annual Global Healthcare Conference at 1:35 PM ET on Wednesday, March 13, 2024 in Miami. Live audio of the...

PCRX - Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results

— Record revenues of $675 million in 2023 — — Full-year GAAP net income of $42 million and adjusted EBITDA of $214 million — — EXPAREL surpasses the 14 million patient mark — — Conference call today...

PCRX - Expected US Company Earnings on Thursday, February 29th, 2024

Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...

PCRX - Learn to Evaluate (PCRX) using the Charts

2024-02-22 15:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PCRX - Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy

– Findings demonstrate significant reduction in pain and opioid consumption through 96 hours versus active comparator – – Significantly greater proportion of opioid-free patients receiving EXPAREL – TAMPA, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Pacira ...

PCRX - Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.

TAMPA, Fla., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc., (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, has been awarded a national group purchasing agreement for Brand Pharmaceuticals with Premier, Inc. Effec...

PCRX - G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams

G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams PR Newswire High Demand for Participation in Pickleball's Big Game on Feb. 9 in Las Vegas Leads to Tournament's Expansion to 24 Teams and Signing of New Sponsors LAS VEGAS , Feb. 1, 2024 ...

PCRX - (PCRX) Investment Report

2024-02-01 04:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PCRX - (PCRX) Investment Analysis and Advice

2024-01-21 06:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Previous 10 Next 10